Novel deep intronic mutation in PLA2G6 causing early-onset Parkinson's disease with brain iron accumulation through pseudo-exon activation.


Journal

Neurogenetics
ISSN: 1364-6753
Titre abrégé: Neurogenetics
Pays: United States
ID NLM: 9709714

Informations de publication

Date de publication:
10 2021
Historique:
received: 22 04 2021
accepted: 04 08 2021
pubmed: 14 8 2021
medline: 4 2 2022
entrez: 13 8 2021
Statut: ppublish

Résumé

PLA2G6 is the causative gene for a group of autosomal recessive neurodegenerative disorders known as PLA2G6-associated neurodegeneration (PLAN). We present a case with early-onset parkinsonism, ataxia, cognitive decline, cerebellar atrophy, and brain iron accumulation. Sequencing of PLA2G6 coding regions identified only a heterozygous nonsense variant, but mRNA analysis revealed the presence of an aberrant transcript isoform due to a novel deep intronic variant (c.2035-274G > A) leading to activation of an intronic pseudo-exon. These results expand the genotypic spectrum of PLAN, showing the paramount importance of detecting possible pathogenic variants in deep intronic regions in undiagnosed patients.

Identifiants

pubmed: 34387792
doi: 10.1007/s10048-021-00667-0
pii: 10.1007/s10048-021-00667-0
pmc: PMC8426226
doi:

Substances chimiques

Group VI Phospholipases A2 EC 3.1.1.4
PLA2G6 protein, human EC 3.1.1.4

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

347-351

Informations de copyright

© 2021. The Author(s).

Références

Eur J Neurol. 2013 Feb;20(2):322-30
pubmed: 22934738
Mov Disord Clin Pract. 2016 Mar 31;4(1):125-128
pubmed: 30868093
Neurology. 2008 Oct 28;71(18):1402-9
pubmed: 18799783
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Clin Genet. 2010 Nov;78(5):432-40
pubmed: 20584031
Hum Genet. 2017 Sep;136(9):1093-1111
pubmed: 28497172
BMC Neurol. 2020 Mar 17;20(1):101
pubmed: 32183746
J Mol Diagn. 2021 Jun;23(6):732-741
pubmed: 33781964
PLoS One. 2016 May 19;11(5):e0155605
pubmed: 27196560
Eur J Paediatr Neurol. 2018 Mar;22(2):272-284
pubmed: 29409688
Ann Neurol. 2009 Jan;65(1):19-23
pubmed: 18570303
Nat Genet. 2006 Jul;38(7):752-4
pubmed: 16783378
Parkinsonism Relat Disord. 2019 Aug;65:159-164
pubmed: 31196701
Front Neurol. 2018 Dec 18;9:1100
pubmed: 30619057
Front Neurol. 2018 Jul 10;9:536
pubmed: 30042723

Auteurs

Chiara Cavestro (C)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Celeste Panteghini (C)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Chiara Reale (C)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Alessia Nasca (A)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Silvia Fenu (S)

Unit of Rare Neurodegenerative and Neurometabolic Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Ettore Salsano (E)

Unit of Rare Neurodegenerative and Neurometabolic Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Luisa Chiapparini (L)

Unit of Neuroradiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Barbara Garavaglia (B)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Davide Pareyson (D)

Unit of Rare Neurodegenerative and Neurometabolic Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Ivano Di Meo (I)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. ivano.dimeo@istituto-besta.it.

Valeria Tiranti (V)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. valeria.tiranti@istituto-besta.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH